Bioporto A/S
CSE:BIOPOR
Bioporto A/S
CSE:BIOPOR
Price:
1.742 DKK
Updated:
May 23, 2024
Bioporto A/S
Research & Development
|
Bioporto A/S
Research & Development Peer Comparison
Comparables:
GMAB
ZEAL
ASND
B
BAVA
SANION
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioporto A/S
CSE:BIOPOR
|
Research & Development
-kr25.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Genmab A/S
CSE:GMAB
|
Research & Development
-kr8.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-38%
|
CAGR 10-Years
-31%
|
|
|
Zealand Pharma A/S
CSE:ZEAL
|
Research & Development
-kr666.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-15%
|
|
|
Ascendis Pharma A/S
NASDAQ:ASND
|
Research & Development
-€370.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
B
|
Bavarian Nordic A/S
CSE:BAVA
|
Research & Development
-kr1.6B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-12%
|
|
|
Saniona AB
STO:SANION
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bioporto A/S's Research & Development?
Research & Development
-25.7m
DKK
-25.7m
DKK
Based on the financial report for Mar 31, 2024, Bioporto A/S's Research & Development amounts to -25.7m DKK.
What is Bioporto A/S's Research & Development growth rate?
Research & Development CAGR 5Y
-9%
-9%
Over the last year, the Research & Development growth was 21%. The average annual Research & Development growth rates for Bioporto A/S have been 2% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
